UniQuest — Technology Transfer Company of The University of Queensland
Australia
UniQuest, University of Queensland's tech-transfer firm since 1984, licensed the Gardasil HPV-vaccine IP and creates spin-outs. Audited UQ accounts confirm …
Australia · Sydney · See the Australia profile
Backed by four Sydney universities since 2000, Cicada Innovations estimates its 25-year economic contribution at AUD 8 billion, built on AUD 6.5 billion raised by portfolio ventures from an initial AUD 20 million public investment — about AUD 400 generated per public dollar.
Cicada Innovations was established around 2000 at the Australian Technology Park in Eveleigh, Sydney, to help reverse the loss of Australia's world-class R&D capability to overseas markets. It is backed by four universities — the University of Sydney, UNSW, UTS and the Australian National University — and was seeded with about AUD 20 million in public investment: roughly AUD 11 million from the Commonwealth's Building Better Cities programme and around AUD 9 million from the NSW Government in land and refurbishment of the National Innovation Centre.
Marking its 25th anniversary in November 2025, Cicada put its cumulative economic contribution at a conservative AUD 8 billion, built on AUD 6.5 billion in capital raised by the deep-tech ventures it has incubated — including Morse Micro, SpeeDx, Regrow, Propeller Aero, Elastagen and Clarity Pharmaceuticals — plus job creation and broader innovation spillovers. That works out to roughly AUD 400 in economic activity for every public dollar originally invested. Since 2023, its Tech23 showcase programme has helped alumni collectively raise over AUD 280 million.
Cicada demonstrates how a multi-university consortium with modest public seed capital can sustain 25 years of deep-tech venture creation. The headline AUD 8 billion figure is Cicada's own conservative estimate combining capital raised, job creation and spillovers — reported consistently across multiple independent outlets, though it is not the product of an independent third-party economic study.
Read the full analysis: https://www.cicadainnovations.com/
Implementation detail (cost, timeline, staffing, conditions for success) is not yet available for this practice.
Where this practice's information was retrieved from, and when.
Australia
UniQuest, University of Queensland's tech-transfer firm since 1984, licensed the Gardasil HPV-vaccine IP and creates spin-outs. Audited UQ accounts confirm …
Canada
Founded in 1999, Mitacs now funds industry-linked graduate internships across all 198 Canadian post-secondary institutions — $292.7m invested in 7,202 …
Belgium
Founded in 1972, KU Leuven's tech-transfer office LRD generated 3,142 industry collaboration agreements, 102 new patents and €152.6 million in …
Switzerland
The EPFL Innovation Park in Lausanne houses 250 high-tech companies and 2,500 researchers, enabling structured university–industry knowledge transfer. EPFL-related startups …
Open full copilot Grounded in cited practices — always check the sources.